1-5 of 5
Eric Parsons
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of CPX-351 As a Novel Therapeutic Approach for Patients with Myelodysplastic Syndromes (MDS) after Hypomethylating Agent Failure

Aziz Nazha, MD, Sudipto Mukherjee, MD PhD MPH, Anjali S Advani, MD, Madeline Waldron, PharmD, BCOP, Caitlin Siebenaller, PharmD, Jenna Thomas, Eric Parsons, RN, Hetty E. Carraway, MD MBA, Aaron T. Gerds, MDMS, Bhumika J. Patel, MD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-139515
Published: 2020
Journal Articles

A Phase I/II Trial of CPX-351 + Palbociclib in Patients with Acute Myeloid Leukemia

Aziz Nazha, MD, Sudipto Mukherjee, MD PhD MPH, Caitlin Siebenaller, PharmD, Madeline Waldron, PharmD, BCOP, Eric Parsons, RN, Jenna Thomas, Hetty E. Carraway, MD MBA, Dale Grabowski, BS, Yihong Guan, PhD, Aaron T. Gerds, MDMS, Bhumika J. Patel, MD, Anjali S Advani, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-139494
Published: 2020
Journal Articles

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy

Sudipto Mukherjee, MD PhD MPH, Hong Li, Brian P. Hobbs, PhD, Aaron T. Gerds, MD MS, Anjali S. Advani, MD, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Samjhana Bogati, RN, Eric Parsons, RN, Benjamin Pannell, Matt Kalaycio, MD, Yogenthiran Saunthararajah, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2595.
https://doi.org/10.1182/blood-2019-132178
Published: 2019
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results

Anjali S. Advani, MD, Brenda W. Cooper, MD, Valeria Visconte, PhD, Paul Elson, PhD, E. Ricky Chan, PhD, Jennifer Carew, PhD, Sudipto Mukherjee, MD PhD MPH, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Paolo Caimi, MD, Benjamin Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Jaime Fensterl, Allison Unger, Cassie Zimmerman, Christopher Goebel, Nita Hoxha, Caitlin Siebenaller, Jenna Thomas, Mary Lynn Rush, RN, Samjhana Bogati, RN, Eric Parsons, RN, Rachael Diligente, RN, Donna Kane, RN, MSN, Alek Nielsen, BS, Cassandra M. Hirsch, BS, Simone Edelheit, Alexander Miron, PhD, John Pink, PhD, Jaroslaw P. Maciejewski, PhD MD FACP, Matt Kalaycio, MD, Marcos De Lima, MD, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 150.
https://doi.org/10.1182/blood.V130.Suppl_1.150.150
Published: 2017
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)

Anjali S. Advani, MD, Brenda Cooper, MD, Paul Elson, PhD, Sudipto Mukherjee, MD, PhD, M.P.H., Jaime Fensterl, Aaron T. Gerds, MD MS, Paolo F. Caimi, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Mary Lynn Rush, Samjhana Bogati, BSN, Eric Parsons, Donna Kane, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Barbara Bevier, Christopher Goebel, Cassie Zimmerman, MPH, Alek d Nielsen, B.S., Cassandra M. Hirsch, BSc, Jaroslaw P. Maciejewski, MD, PhD, FACP, Matt Kalaycio, MD, Marcos deLima, MD, James Jacobberger, Philip Woost, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2016) 128 (22): 4065.
https://doi.org/10.1182/blood.V128.22.4065.4065
Published: 2016